Plain-English translation of NCT07658755 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
LiverSeek is a screening program that automatically checks routine blood work to find people who may have advanced scarring (fibrosis) in their liver. If your initial blood tests suggest possible liver damage, you'll be invited for additional testing including an ultrasound-like scan and a visit with a liver specialist nurse. Some participants will also receive personalized advice on diet and lifestyle changes to help their liver health.
Most people with fatty liver disease and metabolic problems never get checked for dangerous liver scarring, even though guidelines recommend it. This study uses a passive, automated approach that doesn't burden your doctor — instead, the computer system flags at-risk patients based on existing blood tests, making screening much simpler and more likely to catch problems early.
You likely qualify if…
You likely don't qualify if…
If you qualify based on your blood test, you'll be invited to see a liver specialist nurse who will perform a non-invasive ultrasound scan of your liver, take some body measurements, and assess your overall health. You may also be asked to complete some questionnaires about your diet and quality of life. If the scan shows significant scarring, a liver doctor may see you for further evaluation. Some participants will receive a structured visit with personalized diet and lifestyle recommendations and be reassessed after 24 weeks.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Spain